urea has been researched along with tolvaptan in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 5 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hensen, J | 1 |
| Coffernils, M; Couturier, B; Decaux, G; Gankam-Kengne, F; Soupart, A | 1 |
| Frøkjær, J; Jørgensen, JO; Rittig, S; Trolle, C | 1 |
| Bichet, DG | 1 |
| Hatano, M; Imamura, T; Inaba, T; Kato, N; Kinugawa, K; Komuro, I; Kyo, S; Maki, H; Minatsuki, S; Muraoka, H; Shiga, T; Yao, A | 1 |
| Alioto, D; Alonso Pérez, L; Cañamares Orbis, I; Ferrari Piquero, JM; Gómez Valbuena, I | 1 |
| Doi, K; Imamura, T; Kinugawa, K; Nangaku, M; Noiri, E; Shimizu, K; Yahagi, N | 1 |
| Bockenhauer, D; Booth, C; Carroll, A; Dufek, S; Kleta, R; Van't Hoff, W | 1 |
| Abe, M; Fukuhara, E; Fukunami, M; Furukawa, Y; Ikeda, I; Iwasaki, Y; Kawasaki, M; Kikuchi, A; Kondo, T; Morita, T; Nakamura, J; Ozaki, T; Sato, Y; Seo, M; Tamaki, S; Yamada, T | 1 |
| Inomata, T; Kinugawa, K; Sato, N; Shibasaki, Y; Shimakawa, T; Yasuda, M | 1 |
| Agharazii, M; Asselin-Thompstone, L; Côté, G; Desmeules, S; Lacroix, C; Mac-Way, F; René de Cotret, P | 1 |
| Decaux, G; Gankam Kengne, F | 1 |
| Fujisawa, Y; Kidoguchi, S; Kitada, K; Nakano, D; Nishiyama, A; Titze, J; Yokoo, T | 1 |
| Gao, F; Gao, Y; He, X; Liu, W; Shi, L; Wang, W; Zhuang, X | 1 |
| Alexandrou, D; Amin, R; Bockenhauer, D; Dattani, M; Famuboni, A; Gan, HW; Lopez-Garcia, C; Shah, S; Trompeter, R; Veligratli, F | 1 |
3 review(s) available for urea and tolvaptan
| Article | Year |
|---|---|
[Treatment of hyponatremia: new developments and controversies].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Blood Volume; Drinking; Humans; Hyponatremia; Inappropriate ADH Syndrome; Saline Solution, Hypertonic; Sodium; Sodium Chloride; Sodium Chloride Symporter Inhibitors; Tolvaptan; Urea | 2011 |
Hypertonic saline, isotonic saline, water restriction, long loops diuretics, urea or vaptans to treat hyponatremia.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Bicarbonates; Chronic Disease; Drinking; Humans; Hyponatremia; Practice Guidelines as Topic; Saline Solution; Saline Solution, Hypertonic; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan; Urea; Uric Acid | 2020 |
Tolvaptan and urea in paediatric hyponatraemia.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Child; Humans; Hyponatremia; Inappropriate ADH Syndrome; Sodium; Tolvaptan; Treatment Outcome; Urea | 2024 |
2 trial(s) available for urea and tolvaptan
| Article | Year |
|---|---|
Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Morpholines; Sodium; Spiro Compounds; Time Factors; Tolvaptan; Urea | 2012 |
Tolvaptan Reduces the Risk of Worsening Renal Function in Patients With Acute Decompensated Heart Failure and Preserved Left Ventricular Ejection Fraction - Prospective Randomized Controlled Study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Creatinine; Diuretics; Female; Heart Failure; Humans; Kidney Diseases; Male; Middle Aged; Stroke Volume; Tolvaptan; Urea; Ventricular Function, Left; Young Adult | 2017 |
10 other study(ies) available for urea and tolvaptan
| Article | Year |
|---|---|
[Diagnostics and new treatment methods of syndrome of inappropriate antidiuretic hormone secretion (SIADH)].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diagnosis, Differential; Humans; Inappropriate ADH Syndrome; Prognosis; Sodium Chloride; Tolvaptan; Urea; Water-Electrolyte Balance | 2012 |
What is the role of vaptans in routine clinical nephrology?
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Inappropriate ADH Syndrome; Male; Morpholines; Spiro Compounds; Tolvaptan; Urea | 2012 |
Urine osmolality estimated using urine urea nitrogen, sodium and creatinine can effectively predict response to tolvaptan in decompensated heart failure patients.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Chi-Square Distribution; Creatinine; Female; Heart Failure; Hormone Antagonists; Hospitalization; Humans; Male; Middle Aged; Models, Biological; Nitrogen; Osmolar Concentration; Retrospective Studies; Sodium; Time Factors; Tolvaptan; Treatment Outcome; Urea | 2013 |
[Treatment with urea as an alternative to tolvaptan for the syndrome of inappropriate secretion of antidiuretic hormone].
Topics: Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Inappropriate ADH Syndrome; Tolvaptan; Urea | 2014 |
Ratio of urine and blood urea nitrogen concentration predicts the response of tolvaptan in congestive heart failure.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Area Under Curve; Benzazepines; Biomarkers; Blood Urea Nitrogen; Female; Heart Failure; Hospitals, University; Humans; Male; Middle Aged; Patient Selection; Predictive Value of Tests; Prospective Studies; ROC Curve; Tokyo; Tolvaptan; Treatment Outcome; Urea; Urination; Young Adult | 2015 |
Urea is successful in treating inappropriate antidiuretic hormone secretion in an infant.
Topics: Antidiuretic Hormone Receptor Antagonists; Humans; Inappropriate ADH Syndrome; Infant; Male; Tolvaptan; Urea | 2017 |
Novel Risk Score Efficiently Prevents Tolvaptan-Induced Hypernatremic Events in Patients With Heart Failure.
Topics: Aged; Creatinine; Female; Heart Failure; Humans; Hypernatremia; Incidence; Japan; Male; Middle Aged; Potassium; Sodium; Tolvaptan; Urea | 2018 |
Sodium and urea excretion as determinants of urine output in autosomal dominant polycystic kidney disease patients on V2 receptor antagonists: impact of dietary intervention.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Dietary Proteins; Directive Counseling; Diuresis; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Renal Elimination; Retrospective Studies; Sodium; Sodium, Dietary; Tolvaptan; Urea; Urine | 2020 |
Tolvaptan induces body fluid loss and subsequent water conservation in normal rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Body Fluids; Conservation of Water Resources; Rats; Tolvaptan; Urea; Water | 2022 |
Efficacy of tolvaptan in postoperative volume therapy for acute Stanford type A aortic dissection.
Topics: Antidiuretic Hormone Receptor Antagonists; Aortic Dissection; Atrial Fibrillation; Diuretics; Humans; Retrospective Studies; Sodium; Tolvaptan; Urea | 2023 |